Clinical trial
Clinical Evaluation of Enteral-extended Anti-reflux Stents for Pancreatic Pseudocyst
NCT05716594 is registered in ClinicalTrials.gov with Peking University Third Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Evaluation of Enteral-extended Anti-reflux Stents for Pancreatic Pseudocyst
- Lead sponsor
- Peking University Third Hospital
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- March 1, 2023
- Completion date
- December 31, 2025
- Enrollment
- 52 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.